Tools
Tools
Snobre, J, Meehan, CJ 
ORCID: https://orcid.org/0000-0003-0724-8343, Mulders, W, Rigouts, L, Buyl, R, de Jong, BC, Van Rie, A and Tzfadia, O,
2024.
Frameshift mutations in the mmpR5 gene can have a bedaquiline-susceptible phenotype by retaining a protein structure and function similar to wild-type Mycobacterium tuberculosis.
Antimicrobial Agents and Chemotherapy: e00854-24.
ISSN 0066-4804
Preview |
Text
2268913_Meehan.pdf - Published version Download (668kB) | Preview |
Abstract
Bedaquiline (BDQ) is crucial for the treatment of rifampicin-resistant tuberculosis, yet resistance threatens its effectiveness, mainly linked to mutations in the mmpR5 (Rv0678) gene. While frameshift mutations are thought to produce non-functional proteins, we hypothesize that they can result in conserved proteins through late-stop codons or alternative reading frames and remain BDQ susceptible. We extracted 512 isolates harboring frameshift mutations in mmpR5 from the World Health Organization (WHO) catalog and 68 isolates with minimum inhibitory concentration (MIC) in mycobacterial growth indicator tube (MGIT) through a literature review. Using BioPython and AlphaFold2 we computed open (ORF) and alternative reading frames (ARFs) sequences and protein structures and assessed similarity to the wild type using an alignment and template modeling (TM)-score. Among the WHO 512 isolates, 24.8% were BDQ-sensitive. Out of 184 unique frameshift mutations with available nucleotide information, a late-stop codon in the ORF occurred for 32% of the mutations. Also, 40.7% resulted in a conserved sequence, through the ORF or one of the forward ARFs. In 68 isolates with available MGIT MIC data, the presence of late-stop codons in the ORF (OR 4.71, 95% CI 1.36–19.3) or a conserved reading frame (OR 10.4, 95% CI 2.07–102.9) were associated with BDQ sensitivity. Protein structures from the conserved sequences showed high similarity (TM > 0.8). We show that frameshift mutations may retain BDQ susceptibility through late-stop codons in the ORF or conserved ARFs. These findings could improve the prediction of the BDQ phenotype from genomic data and have important implications for treatment decisions. Research Foundation—Flanders, Academy of Medical Sciences, the Wellcome Trust, the Government Department of Business, Energy and Industrial Strategy, the British Heart Foundation and Diabetes UK, and the Global Challenges Research Fund.
| Item Type: | Journal article |
|---|---|
| Publication Title: | Antimicrobial Agents and Chemotherapy |
| Creators: | Snobre, J., Meehan, C.J., Mulders, W., Rigouts, L., Buyl, R., de Jong, B.C., Van Rie, A. and Tzfadia, O. |
| Publisher: | American Society for Microbiology |
| Date: | 24 October 2024 |
| ISSN: | 0066-4804 |
| Identifiers: | Number Type 10.1128/aac.00854-24 DOI 2268913 Other |
| Rights: | © 2024 Snobre et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| Divisions: | Schools > School of Science and Technology |
| Record created by: | Melissa Cornwell |
| Date Added: | 30 Oct 2024 16:16 |
| Last Modified: | 30 Oct 2024 16:16 |
| URI: | https://irep.ntu.ac.uk/id/eprint/52487 |
Actions (login required)
 |
Edit View |
Statistics
Views
Views per month over past year
Downloads
Downloads per month over past year
